Form D · Biotechnology
VALENTX INC
Maple Grove, MN · CIK 0001220832
Offering snapshot reported Feb 19, 2019 · SEC filing
- Reported sold
- $1.97M Offering amount: $5.25M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 1, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 19, 2019 | Initial | $1,971,260 | No comparison | 3 | SEC filing |
| Aug 16, 2018 | Initial | $10,271,050 | No comparison | 32 | SEC filing |
| Sep 3, 2015 | Amendment | $7,500,000 | $3,388,233vs Jul 28, 2014 | 21 | SEC filing |
| Jul 28, 2014 | Initial | $4,111,767 | No comparison | 20 | SEC filing |
| Aug 27, 2009 | Initial | $20,288,949 | No comparison | 24 | SEC filing |
| Oct 15, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 19, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-333067
Source: Form D, filed Feb 19, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jack Ahrens | Director |
| Mary Lincoln Campbell | Director |
| Mitchell Dann | Director |
| Bobby Griffin | Director |
| Elling Halvorson | Director |
| David Krenn | Executive |
| Paul A. Laviolette | Director |
| Paul La Violette | Director |
| Stephen Morrison | Executive |
| Johann Neisz | Director, Executive |
| Dave Sauvageau | Executive |
| Edson W Spencer Jr | Director |
| Jon St. Germain | Director, Executive |
| Gerard Von Hoffmann | Director |
| James Wright | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6901 E. Fish Lake Road, Ste. 118
Maple Grove, MN, 55369
Maple Grove, MN, 55369